GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

The petition was related to a demand of Rs 962.75 crores (including Rs 329.33 crores in interest) raised by the Income Tax ...

In a recent legal development, Hindustan Unilever (NS: HLL) faced a setback regarding a tax dispute involving a significant ...

The Bombay High Court has dismissed Hindustan Unilever Limited's Writ Petition regarding a demand of INR 962.75 Crores by the ...

Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...

Teva Pharmaceutical Industries Ltd. ADR 1.20% $20B ...

GSK PLC GSK shares inched up 0.20% to £15.31 Tuesday, on what proved to be an all-around favorable trading session for the ...

If approved, AZN's Fasenra will be the second biologic approved in the European Union to treat eosinophilic granulomatosis ...

EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

(Reuters) - Sanofi has received two separate bids for its consumer health unit, which could be valued at 15 billion euros ...

The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...